Australia markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.83+0.19 (+1.14%)
At close: 04:00PM EST
16.93 +0.10 (+0.59%)
Pre-market: 05:39AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,387,715
1,146,290
475,598
18,662
34,288
Operating expenses
Research development
1,940,385
2,534,508
747,027
113,842
173,797
Selling general and administrative
411,242
298,358
145,290
34,417
34,409
Total operating expenses
2,892,669
2,832,866
892,317
148,259
208,206
Operating income or loss
-1,225,828
-1,686,576
-416,719
-129,597
-173,918
Interest expense
20,417
21,127
15,145
12,188
12,188
Total other income/expenses net
-52,568
-6,833
13,605
10,515
2,782
Income before tax
-1,298,813
-1,714,536
-418,259
-132,694
-184,748
Income tax expense
23,161
29,215
-
-
-
Income from continuing operations
-1,321,974
-1,743,751
-418,259
-132,694
-184,748
Net income
-1,321,974
-1,743,751
-418,259
-132,694
-184,748
Net income available to common shareholders
-1,321,974
-1,743,751
-418,259
-132,694
-184,748
Basic EPS
-
-23.44
-7.27
-5.51
-10.00
Diluted EPS
-
-23.44
-7.27
-5.51
-10.00
Basic average shares
-
74,400
57,554
24,100
18,488
Diluted average shares
-
74,400
57,554
24,100
18,488
EBITDA
-
-1,680,748
-398,229
-114,830
-164,401